Clearline Capital »

Heron Therapeutics shares owned by Clearline Capital

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Clearline Capital from 13F filings

Historical chart of Clearline Capital investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Clearline Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Clearline Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.4M 2.2M 1.99
2024-06-30 $5.2M 1.5M 3.50
2024-03-31 $7.7M 2.8M 2.77
2023-12-31 $10M 6.1M 1.70
2023-09-30 $6.3M 6.1M 1.03
2023-06-30 $3.1M 2.7M 1.16
2023-03-31 $3.2M 2.1M 1.51
2022-12-31 $2.6M 1.0M 2.50
2020-03-31 $560k 48k 11.75
2019-06-30 $315k 17k 18.62
2019-03-31 $961k 39k 24.43
2018-12-31 $1.0M 39k 25.93
2018-09-30 $974k 31k 31.67